Payoneer’s $7.40 cash sale to Nuvei now governs the stock more than a conventional stand-alone valuation. At the November 6, 2026 close of $7.15, the undiscounted spread was only 3.50%. Our conditional Base scenario is $7.02: an 85% closing probability, an assumed June 30, 2027 cash-receipt date, the $7.40 cash consideration discounted at our 4.5% assumption, and a $6.05 sensitivity midpoint for the deal-break value. Q3 shows a better B2B engine, but the falling take rate, outstanding regulatory and licensing approvals, and the time value of money leave little compensation for a failed or delayed transaction.
Prepared November 7, 2026 KST / November 6 U.S. Eastern, after Q3 results. This is our first Company Research baseline for Payoneer Global Inc. (Nasdaq: PAYO). Financial periods end September 30 unless stated otherwise; amounts are USD. Because stockholders approved a signed take-private transaction, we do not apply a normal long-term independent price target. The valuation is a merger-risk model, and the stand-alone value appears only as an explicit deal-break sensitivity.
Three findings that matter
- The remaining spread is mainly time value. Discounting $7.40 to our assumed June 30, 2027 cash-receipt date at 4.5% produces $7.19, only $0.04 above the November 6 close before assigning any failure risk.
- B2B volume growth is real, but monetization did not keep pace. B2B volume rose 59% while B2B SMB revenue increased 13%; our calculated segment revenue per dollar of volume fell sharply.
- Buybacks reduced outstanding shares, but equity compensation remains material. Nine-month repurchases used $92.5M, stock compensation was $56.7M, and gross issued shares also increased.
What Payoneer sells—and why Nuvei wants it
Payoneer provides a regulated, multi-currency account and payment infrastructure for small and medium-sized businesses, marketplaces and enterprises that operate across borders. A customer can receive marketplace or invoice payments, hold balances in several currencies, convert funds, pay suppliers or contractors, use cards and withdraw to a local bank. Payoneer says its network uses close to 100 banks and payment-service providers, spans more than 7,000 trade corridors and serves customers in more than 190 countries and territories.
The economic model has two parts. First, Payoneer earns fees when customers receive, convert, spend or withdraw funds and when enterprises use its payout infrastructure. Second, it earns interest on customer balances. The second part is meaningful but rate-sensitive: Q3 interest income fell 8% even as customer funds rose 6%. We therefore separate core payment revenue from balance-driven interest income.
Payoneer’s regulatory footprint, local clearing connections and marketplace distribution are difficult to reproduce quickly, but they do not eliminate competition. PayPal, Wise, Airwallex, Ant Group, Bill.com, Adyen, Stripe, banks, regional payment providers and marketplace-owned systems can compete by corridor, product or customer segment. The 2025 Form 10-K also shows concentration: one marketplace represented 21% of revenue and Greater China represented 34%. These dependencies are part of the asset Nuvei is buying and part of the execution risk if the merger fails.
Q3 2026: volume expanded faster than revenue
| Q3 metric | 2026 | 2025 | Change |
|---|---|---|---|
| Total volume | $25.3B | $22.3B | +13% |
| Revenue ex. interest | $222.2M | $211.4M | +5% |
| Interest income | $54.7M | $59.5M | −8% |
| Total revenue | $276.9M | $270.9M | +2% |
| Company take rate | 109 bps | 121 bps | −12 bps |
| Operating income | $25.1M | $36.3M | −31% |
| Adjusted EBITDA | $68.3M | $71.3M | −4% |
The Q3 release and financial statements do not show a simple growth acceleration. Volume increased 13%, but revenue excluding interest grew 5% and total revenue 2%. Transaction costs improved to 15.0% of revenue from 15.7%, yet research and development expense rose 25%, depreciation and amortization rose 32%, and operating income fell to $25.1M. Net income increased 6% to $14.9M because financial income swung positive; it does not reverse the operating-margin decline.
Management’s stronger evidence is customer mix. Average revenue per active customer rose 18% to $555, and ARPU excluding interest grew more than 20% for a ninth consecutive quarter. That is consistent with serving larger customers. It should not be confused with a higher price on every dollar of volume: the consolidated take rate fell from 121 to 109 basis points.
B2B is the growth engine, but revenue yield fell
| Channel | Q3 volume | Growth |
|---|---|---|
| Marketplace SMB | $12.6B | +1% |
| B2B SMB | $5.0B | +59% |
| Checkout | $0.33B | +48% |
| Enterprise payouts | $7.4B | +14% |
| Channel | Q3 revenue | Growth | Revenue / volume |
|---|---|---|---|
| Marketplace SMB | $115M | −5% | 91 bps |
| B2B SMB | $70M | +13% | 140 bps |
| Checkout | $14M | +60% | 424 bps |
| Enterprise payouts | Not disclosed | Not disclosed | Not calculated |
B2B volume grew to $5.0B, driven by larger customers and strength in China and Europe, the Middle East and Africa. But B2B SMB revenue increased much more slowly. Reversing the rounded growth rates gives an approximate prior-year B2B yield of 197 basis points versus 140 basis points in Q3 2026. The exact level is imprecise because the company reports rounded channel data; the decline remains directionally clear despite rounded inputs. Larger customers can add scale while negotiating lower unit economics or using a different product mix.
Marketplace SMBs tell a similar story: volume grew 1%, while revenue fell 5%. Checkout was the exception, with revenue growth outpacing volume and a calculated yield above 400 basis points, but its $330M volume is only about 1.3% of Payoneer’s total. The growth thesis therefore needs both B2B scale and evidence that declining monetization stabilizes.
Cash generation, customer funds and dilution are different pools
| September / nine-month item | Value | AHNIM reading |
|---|---|---|
| Cash and cash equivalents | $362.6M | Corporate cash line; customer funds excluded |
| Customer funds | $7.540B | Matched by operating-balance obligations; not surplus cash |
| Operating cash flow | $180.4M | Up 4.9% year over year |
| PP&E purchases + capitalized software | $25.5M + $50.8M | Recurring platform investment |
| OCF less those investments | $104.0M | AHNIM simple cash measure |
| Stock-based compensation | $56.7M | 55% of simple cash measure |
| Common-stock repurchases | $92.5M | Cash outflow; partly offsets issuance |
Customer funds are not Payoneer’s unrestricted net cash. The balance sheet reports $7.540B of customer funds and the same amount of outstanding operating balances. Treating the customer asset as excess cash would overstate shareholder value. Corporate cash was $362.6M, down from $415.5M at December 2025, after buybacks, acquisitions and other flows.
Our simple $104.0M cash measure subtracts PP&E purchases and capitalized internal-use software from operating cash flow. It is not a company-defined free-cash-flow metric and it does not remove all working-capital or transaction effects. Still, it provides a consistent check on cash conversion. Stock compensation equaled 55% of that simple cash measure, although it was non-cash in the current period.
Repurchases reduced shares outstanding from 348.704M at December 2025 to 340.776M at September 2026, a 2.27% decline. The bridge matters: the 17.566M increase in treasury shares was partly offset by 9.637M more gross issued shares. The filing does not attribute every issued share to stock compensation, so we do not do so either. The net shrinkage reflects the nine-month period; Payoneer said in its Q2 release that repurchases had stopped and would not resume while the transaction is pending. The signed merger fixes common-share consideration at $7.40 under the current agreement rather than rewarding a lower share count with a higher per-share takeout price.
The Nuvei transaction now sets the valuation anchor
Under the signed merger agreement, Nuvei agreed to pay $7.40 per share in cash, implying approximately $2.75B of equity value. Payoneer stockholders approved the agreement on September 14 by 224.985M votes to 2.237M against. The U.S. Hart-Scott-Rodino antitrust waiting period ended early on July 28, removing that named step. Completion still requires the remaining foreign-investment, money-transmitter and other regulatory approvals, plus the absence of a continuing material adverse effect and satisfaction of the other closing conditions.
The agreement permits termination if the merger has not closed by June 12, 2027, with a three-month extension for outstanding regulatory approvals. In specified circumstances Payoneer can owe an $89M termination fee; in specified Nuvei-failure circumstances Nuvei can owe $165M. Those payments are contractual protections, not a guarantee that public shareholders receive $7.40 if the deal fails.
Payoneer withdrew its 2026 and medium-term guidance and stopped earnings calls after announcing the transaction. That is reasonable for a company under contract, but it reduces the normal forecast evidence available to public investors. Q3 operating results remain useful mainly for framing the deal-break sensitivity range and monitoring whether the business stays inside the merger covenants.
AHNIM valuation: a probability-weighted merger spread
| AHNIM scenario | Assumption | Present value |
|---|---|---|
| Bear | Transaction fails; $6.05 current-value sensitivity midpoint | $6.05 |
| Base | 85% probability of discounted $7.40 close; 15% probability of $6.05 break input | $7.02 |
| Bull | Deal consideration discounted to assumed June 30, 2027 receipt at 4.5%; no failure discount | $7.19 |
These are AHNIM assumptions, not company guidance or a prediction of regulatory decisions. The 85% probability reflects completed stockholder approval, the cleared U.S. HSR step and disclosed committed financing, while recognizing that other regulatory and licensing conditions remain. The $6.05 break value is not a derived independent target or a forecast for the future closing date. It is the midpoint of a deliberately broad $5.50–$6.50 current-value sensitivity range, used to expose rather than hide downside uncertainty. A different break price changes the answer materially.
| Deal-break value | 75% close probability | 85% close probability | 95% close probability |
|---|---|---|---|
| $5.50 | $6.77 | $6.94 | $7.11 |
| $6.05 | $6.91 | $7.02 | $7.14 |
| $6.50 | $7.02 | $7.09 | $7.16 |
The raw spread from $7.15 to $7.40 is 3.50%, or approximately 5.46% annualized to our June 30 cash-receipt assumption. But raw annualization ignores the opportunity cost of waiting. At our assumed 4.5% discount rate, the time-value-only present value of the promised cash is $7.19. With the $6.05 current-value sensitivity midpoint, the November 6 price implies roughly a 96% completion probability. That does not mean the market has measured regulatory risk perfectly; it means very little failure compensation remains in the price under these inputs.
Analyst targets mostly restate the deal price
The S&P Global snapshot presented by Stock Analysis, last updated August 7 and reviewed November 7 KST, lists eight analysts with a $7.40 average, median, high and low target. That is the merger consideration, not an independent range of operating valuations. Our unrounded $7.021 Base is 5.12% below the mean, so the difference does not trigger AHNIM’s 20% divergence flag. The comparison is still imperfect: analyst targets are nominal 12-month figures, while our Base explicitly discounts time and failure risk.
We do not use the target average as our valuation input, and we do not infer analyst reasoning from inaccessible research notes. The useful comparison is the visible range: it has collapsed to the signed consideration, while our model keeps time and failure risk explicit.
What would change the baseline
The key positive evidence would be receipt of the remaining named regulatory and license approvals, a firm closing timetable and continued compliance with merger covenants. Each one reduces the probability or duration discount. Strong B2B growth and stable cash generation can support a higher deal-break sensitivity input, but they do not lift the signed $7.40 consideration.
We would reduce the Base probability for a material regulatory remedy, extended review beyond the contractual timetable, a disclosed impairment or change in committed financing, a material adverse business change, or evidence that marketplace and China concentration justify a lower stand-alone sensitivity input. A delay can reduce value even if the deal ultimately closes because the cash payment does not accrue interest.
For a contrasting payments-infrastructure model without a signed take-private cap, see our Marqeta volume and monetization analysis. For a consumer-finance model where credit risk drives valuation, see our Dave funding and credit-risk research. More first-principles baselines are available in Company Research.
Our conclusion: Payoneer’s operating franchise is improving in B2B scale, but the public-stock question is now narrower. At $7.15, investors are paying almost the full discounted value of $7.40 while retaining regulatory, timing and deal-break risk. The Q3 numbers support using a higher part of our downside sensitivity range than the weakest case, but they do not establish a guaranteed floor or create uncapped upside under the signed agreement.
For information and education, not personalized investment advice. Conditional estimates can change materially; no investment return or merger completion is guaranteed.
Sources and original documents
- Payoneer Q3 2026 results and financial statements, November 5, 2026 — channel metrics, income statement, balance sheet, cash flow and non-GAAP reconciliation.
- Payoneer Q3 2026 Form 10-Q, filed November 5, 2026, accession 0001104659-26-123314.
- Payoneer merger Form 8-K, June 15, 2026 — $7.40 consideration, conditions, outside date and termination fees.
- Payoneer stockholder-vote Form 8-K, September 14, 2026 — approval and vote counts.
- Payoneer 2025 Form 10-K, February 26, 2026 — business model, competition, marketplace and geographic concentration.
- Nuvei–Payoneer transaction announcement, June 15, 2026 — transaction value, strategic rationale and expected timetable.
- Payoneer Q2 2026 results, August 6, 2026 — July 28 HSR early termination, guidance withdrawal and repurchase pause.
- Stock Analysis / S&P Global analyst snapshot, reviewed November 7, 2026 KST — eight-target mean, median and range; latest actions are secondary-source data.
- AHNIM approach and valuation policy — editorial responsibility, AI use and correction policy.